Skip to content

Physical Examination-Indicated Pessary

Status
Withdrawn
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02967445
Enrollment
0
Registered
2016-11-18
Start date
2016-11-30
Completion date
2018-03-31
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PreTerm Birth

Brief summary

Cervical insufficiency, previously referred to as cervical incompetence, has classically been defined as painless dilation of the cervix in the absence of contractions or bleeding in the second trimester resulting in recurrent pregnancy losses. Painless mid-trimester cervical dilation is an uncommon finding in the general population occurring in less than 1% of pregnancies. Cerclage for the prevention pregnancy loss in cases with both prior preterm births and/or second trimester losses, as well as second trimester cervical dilatation in the index pregnancy, was first reported in the 1950's. Cerclage placement in this setting has been variably referred to as physical exam-indicated cerclage, rescue cerclage, and emergency cerclage. To date, the benefits of cerclage for this indication are not entirely clear. A recent meta-analysis showed that physical exam-indicated cerclage is associated with a reduction in perinatal mortality and prolongation of pregnancy when compared to no such cerclage. Recently, several RCTs have shown that cervical pessary could decrease the incidence of PTB in several populations. Thus, the aim of our trial as noninferiority trial is to evaluate the efficacy of pessary compared to cervical cerclage in prevention of PTB in women in the setting of mid-trimester cervical dilation

Interventions

Arabin silicon pessary

Sponsors

Federico II University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Singleton pregnancies * Cervical dilation between 1 to 5 cm and/or visible membranes by pelvic exam or speculum exam between at 16-23 6/7 weeks gestation

Exclusion criteria

* Pessary or cerclage already in situ * active vaginal bleeding * Placenta previa/accreta * Multiple gestations * Amniotic membranes prolapsed beyond external os into the vagina, unable to visualize cervical tissue * Ruptured amniotic membranes at the time of diagnosis of dilated cervix * Cervical dilation more than 5 cm * Labor (progressing cervical dilation) or painful regular uterine contractions

Design outcomes

Primary

MeasureTime frame
Neonatal survivalFrom delivery to 28 days

Secondary

MeasureTime frameDescription
Preterm birthtime of delivery\<24, \<28, \<30 weeks. both spontaneous and indicated
Latencytime of deliveryTime from randomization to delivery
Birth weighttime of deliveryin grams
gestational age at deliverytime of deliverymean of delivery

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026